author-photo

Nancy Tait

University of Maryland Marlene and Stewart Greenebaum Cancer Center

36

Papers

513

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

Abstract 5532: Serum progranulin (GP88) level correlates with change in RECIST and survival in metastatic breast cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P1-02-12: Determination of a serum progranulin (GP88/PGRN) level associated with overall survival in metastatic breast cancer patients

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Antiemetic efficacy of transcutaneous electrical nerve stimulation (TENS) at pericardium 6 acupuncture point (P6) in the treatment of chemotherapy-induced delayed nausea and vomiting (CINV) in stage I to III breast cancer patients during adjuvant/neoadjuvant chemotherapy (Ad/nAd).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Changes in patient-reported outcomes in women with breast cancer in a multicenter double-blind randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms (AIMSS).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Association of serum levels of the growth factor GP88 with disease progression in breast cancer patients

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of Predictors.

2016 American Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Abstract 3918: Circulating progranulin (GP88/PGRN) level correlates with survival in metastatic breast cancer patients

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Adjuvant aromatase inhibitor adherence based on the Morisky Medication Adherence Scale and identification of predictors to adherence.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-19-05: Combination vorinostat and lapatinib reverses epithelial-mesenchymal transition, inhibits the cancer stem cell population of HER2+ breast cancer cells and is effective in heavily pretreated advanced tumors

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT2-1-03: A pilot and phase II study of entinostat and anastrozole/tamoxifen in women with triple negative breast cancer (TNBC) to evaluate biomarkers and surrogates for response

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)